Paid Clinical Trials Alabama

Discover 1,088 paid clinical trials in Alabama. Search by city or condition to find a research study near you that matches your needs across various therapeutic areas.

Filter

Filter results

Results: 1,088

RavulizumabStudy of Ravulizumab in Immunoglobulin A Nephropathy (IgAN)

Recruiting

PHASE3

Sponsor:

Alexion Pharmaceuticals, Inc.

Location:

Alabaster AL, Acworth GA, Lawrenceville GA, Knoxville TNshow 35 more

Code:

NCT06291376

Conditions

Immunoglobulin A Nephropathy

IgAN

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

Ravulizumab

Placebo

CLN-619 & PembrolizumabA Study of CLN-619 Alone and in Combination With Pembrolizumab in Advanced Solid Tumors

Recruiting

PHASE1

Sponsor:

Cullinan Therapeutics Inc.

Location:

Birmingham AL, Nashville TN, Huntersville NC, Sarasota FLshow 8 more

Code:

NCT05117476

Conditions

Advanced Solid Tumor

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

CLN-619

Pembrolizumab

Observational StudyProduct Surveillance Registry

Recruiting

Sponsor:

Medtronic

Location:

Birmingham AL, Huntsville AL, Panama City FL, Gainesville GAshow 133 more

Code:

NCT01524276

Conditions

Cardiac Rhythm Disorders

Urological Disorders

Neurological Disorders

Cardiovascular Disorders

Digestive Disorders

Eligibility Criteria

Sex: All

Age: 0 - 70+

Healthy Volunteers: Not accepted

VX-993Evaluation of Efficacy and Safety of VX-993 for Pain Associated With Diabetic Peripheral Neuropathy

Recruiting

PHASE2

Sponsor:

Vertex Pharmaceuticals Incorporated

Location:

Cullman AL, Atlanta GA, Decatur GA, Moncks Corner SCshow 23 more

Code:

NCT06619860

Conditions

Diabetic Peripheral Neuropathic Pain

Eligibility Criteria

Sex: All

Age: 18 - 70+

Healthy Volunteers: Not accepted

Interventions

VX-993

Pregabalin

Placebo (matched to pregabalin)

Placebo (matched to VX-993)

TAK-279A Study of TAK-279 in Participants With Moderate-to-Severe Plaque Psoriasis

Recruiting

PHASE3

Sponsor:

Takeda

Location:

Hoover AL, Birmingham AL, Marietta GA, Atlanta GAshow 85 more

Code:

NCT06550076

Conditions

Plaque Psoriasis

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

TAK-279

Amyloid RemovalDIAN-TU Amyloid Removal Trial (ART) in Dominantly Inherited Alzheimer's Disease

Recruiting

PHASE3

Sponsor:

Washington University School of Medicine

Location:

Birmingham AL, Saint Louis MO, Indianapolis IN, Seattle WA

Code:

NCT06384573

Conditions

Alzheimer's Disease

Dementia

Alzheimer's Disease, Familial

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

lecanemab

SelgantolimodStudy of Oral TLR8 Agonist Selgantolimod on HBsAg in Participants With Both Chronic Hepatitis B and HIV

Recruiting

PHASE2

Sponsor:

National Institute of Allergy and Infectious Diseases (NIAID)

Location:

Birmingham AL, Atlanta GA, Nashville TN, Saint Louis MOshow 20 more

Code:

NCT05551273

Conditions

Hepatitis B

HIV Infections

Eligibility Criteria

Sex: All

Age: 18 - 70

Healthy Volunteers: Not accepted

Interventions

Selgantolimod

Placebo

Observational StudyA Study About How Blood Cell Growth Patterns Relate to Heart Health After Treatment for Hodgkin Lymphoma

Recruiting

Sponsor:

Children's Oncology Group

Location:

Mobile AL, Knoxville TN, Tampa FL, Orlando FLshow 19 more

Code:

NCT05705531

Conditions

Cardiovascular Disorder

Clonal Hematopoiesis

Hodgkin Lymphoma

Eligibility Criteria

Sex: All

Age: 7 - 40

Healthy Volunteers: Not accepted

Interventions

Biospecimen Collection

Electronic Health Record Review

Magnetic Resonance Imaging

Survey Administration

Dynamic Compression NailThe Use of a Dynamic Compression Intramedullary Nail for Tibiotalocalcaneal Arthrodesis

Recruiting

Sponsor:

MedShape, Inc

Location:

Birmingham AL

Code:

NCT04784273

Conditions

Ankle Arthritis

Foot Arthritis

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

Tibiotalocalcaneal Arthrodesis

DynaNail

SelinexorSelinexor in Maintenance Therapy After Systemic Therapy for Participants With p53 Wild-Type, Advanced or Recurrent Endometrial Carcinoma

Recruiting

PHASE3

Sponsor:

Karyopharm Therapeutics Inc

Location:

Birmingham AL, Atlanta GA, Chattanooga TN, Gainesville GAshow 71 more

Code:

NCT05611931

Conditions

Endometrial Cancer

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

Selinexor

Matching Placebo for selinexor

Popular cities in Alabama

Mobile Tuscaloosa Birmingham Montgomery